Emergence of Carbapenem-Resistant Pseudomonas aeruginosa and Acinetobacter baumannii Clinical Isolates Collected from Some Libyan Hospitals

Microbial Drug Resistance

Volumn 21, Issue 3, 2015, Pages 335-341

  Mathlouthi, Najla ^a,b   Areig, Zaynab ^c,d   Al Bayssari, Charbel ^a   Bakour, Sofiane ^a   El Salabi, Allaaeddin Ali ^c,e   Ben Gwierif, Salha ^d,e   Zorgani, Abdulaziz A ^f   Ben Slama, Karim ^b   Chouchani, Chedly ^b,g   Rolain, Jean Marc ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

^b UNIVERSITY OF TUNIS EL MANAR   (Tunisia)

^c Benghazi Medical Centre   (Libyan Arab Jamahiriya)

^d Department of Computer Science   (Libyan Arab Jamahiriya)

^e UNIVERSITY OF BENGHAZI   (Libyan Arab Jamahiriya)

^f UNIVERSITY OF TRIPOLI   (Libyan Arab Jamahiriya)

^g UNIVERSITY OF CARTHAGE   (Tunisia)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AZTREONAM; BETA LACTAMASE; CARBAPENEM; CARBAPENEMASE; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CLAVULANIC ACID; COLISTIN; EDETIC ACID; GENTAMICIN; IMIPENEM; MEROPENEM; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; TICARCILLIN; TOBRAMYCIN; ANTIINFECTIVE AGENT; OPRD PROTEIN, PSEUDOMONAS AERUGINOSA; PORIN;

ACINETOBACTER BAUMANNII; AMINO ACID SEQUENCE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL MUTATION; BACTERIUM ISOLATE; BURN UNIT; CLONAL VARIATION; GENE SEQUENCE; HOSPITAL; HOSPITAL DEPARTMENT; INTENSIVE CARE UNIT; LIBYAN ARAB JAMAHIRIYA; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MINIMUM INHIBITORY CONCENTRATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SEQUENCE ANALYSIS; STOP CODON; TRACHEA; URINARY TRACT; WOUND; ACINETOBACTER INFECTIONS; CHEMISTRY; CLASSIFICATION; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MULTILOCUS SEQUENCE TYPING; MUTATION; PHYLOGENY; PLASMID; PSEUDOMONAS INFECTIONS;

ACINETOBACTER BAUMANNII; PSEUDOMONAS AERUGINOSA;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; GENE EXPRESSION REGULATION, BACTERIAL; HOSPITALS; HUMANS; IMIPENEM; LIBYA; MICROBIAL SENSITIVITY TESTS; MULTILOCUS SEQUENCE TYPING; MUTATION; PHYLOGENY; PLASMIDS; PORINS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

EID: 84930247023     PISSN: 10766294     EISSN: 19318448     Source Type: Journal    
DOI: 10.1089/mdr.2014.0235     Document Type: Article

References (39)

1. Al Bayssari, C., S.M. Diene, L. Loucif, S.K. Gupta, F. Dabboussi, H. Mallat, M. Hamze, and J.M. Rolain. 2014. Emergence of VIM-2 and IMP-15 carbapenemases and inactivation of oprD gene in carbapenem-resistant Pseudomonas aeruginosa clinical isolates from lebanon. Antimicrob. Agents Chemother. 58:4966-4970.
2. Al-Agamy, M.H., N.G. Khalaf, M.M. Tawfick, A.M. Shibl, and A. El Kholy. 2014. Molecular characterization of carbapenem-insensitive Acinetobacter baumannii in Egypt. Int. J. Infect. Dis. 22:49-54.
3. Bakour, S., S.A. Alsharapy, A. Touati, and J.M. Rolain. 2014. Characterization of Acinetobacter baumannii clinical isolates carrying bla carbapenemase and 16S rRNA methylase armA genes in Yemen. Microb. Drug Resist. 20:604-609.
4. Bakour, S., M. Kempf, A. Touati, A.A. Ait, D. Haouchine, F. Sahli, and J.M. Rolain. 2012. Carbapenemase-producing Acinetobacter baumannii in two university hospitals in Algeria. J. Med. Microbiol. 61:1341-1343.
5. Bartual, S.G., H. Seifert, C. Hippler, M.A. Luzon, H. Wisplinghoff, and F. Rodriguez-Valera. 2005. Development of a multilocus sequence typing scheme for characterization of clinical isolates of Acinetobacter baumannii. J. Clin. Microbiol. 43:4382-4390.
6. Cabot, G., A.A. Ocampo-Sosa, F. Tubau, M.D. Macia, C. Rodriguez, B. Moya, L. Zamorano, C. Suarez, C. Pena, L. Martinez-Martinez, and A. Oliver. 2011. Overexpression of AmpC and efflux pumps in Pseudomonas aeruginosa isolates from bloodstream infections: prevalence and impact on resistance in a Spanish multicenter study. Antimicrob. Agents Chemother. 55:1906-1911.
7. Chouchani, C., R. Marrakchi, and A. El Salabi. 2011. Evolution of beta-lactams resistance in Gram-negative bacteria in Tunisia. Crit. Rev. Microbiol. 37:167-177.
8. Chouchani, C., R. Marrakchi, L. Ferchichi, A. El Salabi, and T.R. Walsh. 2011. VIM and IMP metallo-beta-lactamases and other extended-spectrum beta-lactamases in Escherichia coli and Klebsiella pneumoniae from environmental samples in a Tunisian hospital. APMIS 119:725-732.
9. Cornaglia, G., H. Giamarellou, and G.M. Rossolini. 2011. Metallo-beta-lactamases: a last frontier for beta-lactams? Lancet Infect. Dis. 11:381-393.
10. Corvec, S., L. Poirel, J.W. Decousser, P.Y. Allouch, H. Drugeon, and P. Nordmann. 2006. Emergence of carbapenem-hydrolysing metallo-beta-lactamase VIM-1 in Pseudomonas aeruginosa isolates in France. Clin. Microbiol. Infect. 12:941-942.
11. Diene, S.M., B. Fall, M. Kempf, F. Fenollar, K. Sow, B. Niang, B. Wade, D. Raoult, and J.M. Rolain. 2013. Emergence of the OXA-23 carbapenemase-encoding gene in multidrug-resistant Acinetobacter baumannii clinical isolates from the Principal Hospital of Dakar, Senegal. Int. J. Infect. Dis. 17:209-210.
12. Diene, S.M., and J.M. Rolain. 2014. Carbapenemase genes and genetic platforms in Gram-negative bacilli: Enterobacteriaceae, Pseudomonas and Acinetobacter species. Clin. Microbiol. Infect. 20:831-838.
13. Dortet, L., L. Poirel, C. Errera, and P. Nordmann. 2014. CarbAcineto NP test for rapid detection of carbapenemase-producing Acinetobacter spp. J. Clin. Microbiol. 52:2359-2364.
14. Dortet, L., L. Poirel, and P. Nordmann. 2012. Rapid identification of carbapenemase types in Enterobacteriaceae and Pseudomonas spp. by using a biochemical test. Antimicrob. Agents Chemother. 56:6437-6440.
15. El, A.N., C.G. Giske, S. Jalal, B. Keijser, G. Kronvall, and B. Wretlind. 2005. Carbapenem resistance mechanisms in Pseudomonas aeruginosa: alterations of porin OprD and efflux proteins do not fully explain resistance patterns observed in clinical isolates. APMIS 113:187-196.
16. El, S.A., P.S. Borra, M.A. Toleman, O. Samuelsen, and T.R. Walsh. 2012. Genetic and biochemical characterization of a novel metallo-beta-lactamase, TMB-1, from an Achromobacter xylosoxidans strain isolated in Tripoli, Libya. Antimicrob. Agents Chemother. 56:2241-2245.
17. Ellabib, M.S., M. Aboshkiwa, N. Almargani, A. Zorgani, A. El Salabi, and M. El-Gumati. 2013. Detection of metallo-β-lactamase in Pseudomonas aeruginosa from Tripoli, Libya. J. Biomed. Sci. 2:1-6.
18. Evans, B.A., and S.G. Amyes. 2014. OXA beta-lactamases. Clin. Microbiol. Rev. 27:241-263.
19. Gutierrez, O., C. Juan, E. Cercenado, F. Navarro, E. Bouza, P. Coll, J.L. Perez, and A. Oliver. 2007. Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Spanish hospitals. Antimicrob. Agents Chemother. 51:4329-4335.
20. Hammami, S., V. Gautier, R. Ghozzi, C.A. Da, S. Ben-Redjeb, and G. Arlet. 2010. Diversity in VIM-2-encoding class 1 integrons and occasional blaSHV2a carriage in isolates of a persistent, multidrug-resistant Pseudomonas aeruginosa clone from Tunis. Clin. Microbiol. Infect. 16: 189-193.
21. Kempf, M., and J.M. Rolain. 2012. Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic options. Int. J. Antimicrob. Agents 39:105-114.
22. Lee, K., C.K. Kim, D. Yong, S.H. Jeong, J.H. Yum, Y.H. Seo, J.D. Docquier, and Y. Chong. 2010. Improved performance of the modified Hodge test with MacConkey agar for screening carbapenemase-producing Gram-negative bacilli. J. Microbiol. Methods 83:149-152.
23. Lister, P.D., D.J. Wolter, and N.D. Hanson. 2009. Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms. Clin. Microbiol. Rev. 22:582-610.
24. Livermore, D.M. 2002. Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare? Clin. Infect. Dis. 34:634-640.
25. Mansour, W., L. Poirel, D. Bettaieb, O. Bouallegue, N. Boujaafar, and P. Nordmann. 2008. Dissemination of OXA-23-producing and carbapenem-resistant Acinetobacter baumannii in a University Hospital in Tunisia. Microb. Drug Resist. 14:289-292.
26. Mavroidi, A., A. Tsakris, E. Tzelepi, S. Pournaras, V. Loukova, and L.S. Tzouvelekis. 2000. Carbapenem-hydrolysing VIM-2 metallo-beta-lactamase in Pseudomonas aeruginosa from Greece. J. Antimicrob. Chemother. 46:1041-1042.
27. Nehme, D., X.Z. Li, R. Elliot, and K. Poole. 2004. Assembly of the MexAB-OprM multidrug efflux system of Pseudomonas aeruginosa: identification and characterization of mutations in mexA compromising MexA multimerization and interaction with MexB. J. Bacteriol. 186:2973-2983.
28. Nho, S.O., J.S. Jin, J.W. Kim, J.Y. Oh, J. Kim, Y.C. Lee, S.Y. Seol, D.T. Cho, and J.C. Lee. 2008. Dissemination of the blaIMP-1 and blaVIM-2 metallo-beta-lactamase genes among genetically unrelated Pseudomonas aeruginosa isolates in a South Korean hospital. Int. J. Antimicrob. Agents 31:586-588.
29. Nordmann, P., and L. Poirel. 2014. The difficult-to-control spread of carbapenemase producers in Enterobacteriaceae worldwide. Clin. Microbiol. Infect. 20:821-830.
30. Nordmann, P., and L. Poirel. 2014. Emerging and important antibiotic resistance in Gram negative bacteria: epidemiology, theory and practice. Rev. Med. Suisse 10:902-907.
31. Pirnay, J.P., V.D. De, D. Mossialos, A. Vanderkelen, P. Cornelis, and M. Zizi. 2002. Analysis of the Pseudomonas aeruginosa oprD gene from clinical and environmental isolates. Environ. Microbiol. 4:872-882.
32. Poirel, L., and P. Nordmann. 2006. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin. Microbiol. Infect. 12:826-836.
33. Rafei, R., F. Dabboussi, M. Hamze, M. Eveillard, C. Lemarie, H. Mallat, J.M. Rolain, M.L. Joly-Guillou, and M. Kempf. 2014. First report of blaNDM-1-producing Acinetobacter baumannii isolated in Lebanon from civilians wounded during the Syrian war. Int. J. Infect. Dis. 21:21-23.
34. Rojo-Bezares, B., V. Estepa, R. Cebollada, T.M. de, S. Somalo, C. Seral, F.J. Castillo, C. Torres, and Y. Saenz. 2014. Carbapenem-resistant Pseudomonas aeruginosa strains from a Spanish hospital: characterization of metallo-beta-lactamases, porin OprD and integrons. Int. J. Med. Microbiol. 304:405-414.
35. Sanbongi, Y., A. Shimizu, T. Suzuki, H. Nagaso, T. Ida, K. Maebashi, and N. Gotoh. 2009. Classification of OprD sequence and correlation with antimicrobial activity of carbapenem agents in Pseudomonas aeruginosa clinical isolates collected in Japan. Microbiol. Immunol. 53:361-367.
36. Sefraoui, I., M. Berrazeg, M. Drissi, and J.M. Rolain. 2014. Molecular epidemiology of carbapenem-resistant Pseudomonas aeruginosa clinical strains isolated from western Algeria between 2009 and 2012. Microb. Drug Resist. 20:156-161.
37. Touati, M., S.M. Diene, M. Dekhil, A. Djahoudi, A. Racherache, and J.M. Rolain. 2013. Dissemination of a class I integron carrying VIM-2 carbapenemase in Pseudomonas aeruginosa clinical isolates from a hospital intensive care unit in Annaba, Algeria. Antimicrob. Agents Chemother. 57:2426-2427.
38. Yong, D., K. Lee, J.H. Yum, H.B. Shin, G.M. Rossolini, and Y. Chong. 2002. Imipenem-EDTA disk method for differentiation of metallo-beta-lactamase-producing clinical isolates of Pseudomonas spp. and Acinetobacter spp. J. Clin. Microbiol. 40:3798-3801.
39. Zafer, M.M., M.H. Al-Agamy, H.A. El-Mahallawy, M.A. Amin, and M.S. Ashour. 2014. Antimicrobial resistance pattern and their beta-lactamase encoding genes among Pseudomonas aeruginosa strains isolated from cancer patients. Biomed. Res. Int. doi: 10.1155/2014/101635.